NCT00337922View on ClinicalTrials.gov

Pharmacokinetic Study Of EPZICOM Tablet

PHASE4CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

July 31, 2006

Conditions
HIV Infection
Interventions
DRUG

Lamivudine / Abacavir Sulfate

Trial Locations (4)

384-0301

GSK Investigational Site, Nagano

540-0006

GSK Investigational Site, Osaka

432-8002

GSK Investigational Site, Shizuoka

162-0052

GSK Investigational Site, Tokyo

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY